Gujarat Inject Whole-Time Director Deepak Bachwani passes away
Gujarat Inject (Kerala) Ltd announced the demise of Mr. Deepak Diwan Bachwani, who served as Whole-Time Director, Chief Financial Officer, and Chairman, on 23 June 2026. Consequently, he ceased to hold the positions of Whole-Time Director and Chief Financial Officer effective from the same date. The Board expressed condolences to the bereaved family.

*this image is generated using AI for illustrative purposes only.
Gujarat Inject (Kerala) Ltd announced the demise of Mr. Deepak Diwan Bachwani, who served as Whole-Time Director, Chief Financial Officer, and Chairman, on 23 June 2026. The company informed the exchanges that his passing necessitates changes to its leadership structure, with Mr. Bachwani ceasing to be the Whole-Time Director and Chief Financial Officer effective immediately. The Board of Directors expressed their deepest condolences to the bereaved family, acknowledging his invaluable guidance and contribution during his tenure.
The disclosure was made to BSE Limited pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company also provided details as required under SEBI Circular No. CIRCULARHO/49/14/14(7)2025-CFD-POD2/1/3762/2026 dated 30th January 2026.
The regulatory filing outlined the specifics of the cessation of office. The reason for the change was recorded as death, with the date of cessation noted as 23 June 2026. The document confirmed that the departing director did not hold directorships in any other listed entities.
Key Disclosures
| Particulars | Details |
|---|---|
| Reason for change | Death |
| Date of Cessation | 23 June 2026 |
| Brief profile | Not Applicable |
| Relationships between directors | Not Applicable |
| Directorships in other listed entities | None |
Historical Stock Returns for Gujarat Inject
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -4.33% | +0.82% | +14.64% | +244.06% | +345.06% | +4,716.87% |
Who will the Board appoint to fill the immediate vacancy for Whole-Time Director and Chief Financial Officer?
What is the expected timeline for announcing a permanent successor to the Chairman role?
How will the company manage the transition of financial oversight during this interim period?

































